ArticleCancer gene therapy2024

BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors.

Anthony P Conley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.